Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2015 Oct 26;17(21):5160–5163. doi: 10.1021/acs.orglett.5b02376

Palladium-Catalyzed Enantioselective Decarboxylative Allylic Alkylation of Cyclopentanones

Robert A Craig II 1, Steven A Loskot 1, Justin T Mohr 1, Douglas C Behenna 1, Andrew M Harned 1, Brian M Stoltz 1,*
PMCID: PMC4640231  PMID: 26501770

Abstract

graphic file with name ol-2015-02376h_0004.jpg

The first general method for the enantioselective construction of all-carbon quaternary centers on cyclopentanones by enantioselective palladium-catalyzed decarboxylative allylic alkylation is described. Employing the electronically modified (S)-(p-CF3)3-t-BuPHOX ligand, α-quaternary cyclopentanones were isolated in yields up to >99% with ee’s up to 94%. Additionally, in order to facilitate large-scale application of this method, a low catalyst loading protocol was employed, using as little as 0.15 mol % Pd, furnishing the product without any loss in ee.


The efficient construction of all-carbon quaternary centers (Cq’s) remains a challenge for the modern synthetic chemist.1 The difficulty associated with forming Cq’s arises from the inherent steric congestion during the C–C bond-forming event. Toward this end, our laboratory disclosed the first palladium-catalyzed enantioselective decarboxylative allylic alkylation for the construction of Cq’s.2 Over the past decade, we have continued to explore the breadth of our reaction manifold,3 including the development of new ligands based on the original phosphinooxazoline (PHOX) scaffold.4 Cyclic ketones generally represent the most explored class of substrates, from the initially reported cyclohexanones (Scheme 1A),2,5 cycloheptanones,2,3d,5b,5c and cyclooctanones2,3d,5b to the more recently disclosed and highly strained cyclobutanones (Scheme 1B).6

Scheme 1. Cyclic Ketone Substrates in Transition-Metal-Catalyzed Enantioselective Decarboxylative Allylic Alkylation.

Scheme 1

Contrastingly, cyclopentanones have typically performed worse than the corresponding 6-membered substrates, often furnishing the α-Cq ketone products in comparatively reduced yields and enantiomeric excess (ee).3d Only a few examples with limited substrate scope exist for the formation of α-Cq cyclopentanones by transition-metal-catalyzed enantioselective allylic alkylation.7 However, cyclopentanes containing enantioenriched Cq’s characterize a number of biologically pertinent and chemically fascinating natural products, including polycyclic terpenoids 7,88,9 and 9(10) as well as alkaloids 10,1111,11 and 12(12) (Figure 1). As part of our continued efforts to extend the utility of our reaction methodology, we revisited the problematic cyclopentanone substrate class, striving to develop the first general method for the construction of α-Cq cyclopentanones and 5-membered cyclic ketone substrates by transition metal-catalyzed enantioselective decarboxylative allylic alkylation (Scheme 1C).

Figure 1.

Figure 1

Natural products characterized by cyclopentane rings containing chiral all-carbon quaternary centers (Cq’s).

Initial reaction development employed p-Me-benzyl-substituted β-ketoester 13a, using catalytic Pd2(dba)3 at 20 °C in toluene in the presence of a chiral PHOX ligand, affording enantioenriched α-Cq cyclopentanone 14a (Table 1).13,14 Using the classic (S)-t-BuPHOX ligand ((S)-L1), cyclopentanone (S)-14a was provided in 87% ee (entry 1). Switching to the electron-deficient (S)-(p-CF3)3-t-BuPHOX ((S)-L2) furnished product (S)-14a in an improved 89% ee (entry 2). The recently disclosed, cost-effective alternative to L2, (R)-(p-CF3)3-i-PrPHOXMe2 ((R)-L3), provided cyclic ketone (R)-14a in a decreased 83% ee (entry 3).4a Similarly to (R)-L3, geminally disubstituted valine-derived (S)-(p-CF3)2-i-PrPHOXPh2 ((S)-L4) afforded ketone (S)-14a with nearly equivalent ee (82%, entry 4). Switching to ester-substituted β-ketoester 13b, we confirmed (S)-(p-CF3)3-t-BuPHOX ((S)-L2) was indeed the optimal ligand for the desired enantioselective decarboxylative allylic alkylation, providing enantioenriched α-Cq cyclopentanone (S)-14b in 91% ee (entry 6). The remaining PHOX ligands (S)-L1, (R)-L3, and (S)-L4 furnished the desired product (14b) in reduced ee’s, ranging between 80% and 82% (entries 5, 7, and 8, respectively).

Table 1. PHOX Ligand Screena.

graphic file with name ol-2015-02376h_0002.jpg

a

Conditions: β-ketoester 13 (0.19 mmol), Pd2(dba)3 (2.75 mol %), ligand (6.00 mol %), toluene (5.8 mL).

b

Measured by analytical chiral SFC.

Having identified the optimal ligand for the enantioselective decarboxylative allylic alkylation, we next examined the solvent effect using β-ketoester 13b (Table 2). Employing identical reaction conditions from our ligand screen, using toluene as the solvent, we isolated α-Cq cyclopentanone (S)-14b in 91% ee, achieving complete consumption of starting material 13b in 8.0 h (entry 1). Switching to the less polar solvent mixture 2:1 hexanes/toluene, which has previously provided increased ee’s for other α-Cq cyclic ketones constructed through palladium-catalyzed enantioselective decarboxylative allylic alkylation,15 did not affect the reaction time but furnished ketone (S)-14b in a diminished 88% ee (entry 2). Changing to ethereal solvents (entries 3 and 4) drastically decreased the reaction time, facilitating the full consumption of β-ketoester 13b in 1.0 h. While the use of MTBE (entry 3) afforded cyclopentanone (S)-14b in nearly identical ee to the mixed nonpolar solvent system (entry 2), switching to THF (entry 4) proved deleterious. Ultimately, the use of Pd2(dba)3 (2.75 mol %) with (S)-(p-CF3)3-t-BuPHOX ((S)-L2, 6.00 mol %) in toluene (0.033 M in β-ketoester 13b) at 20 °C proved optimal.

Table 2. Solvent Effect on Enantiomeric Excess of Cyclopentanone Product (S)-14ba.

graphic file with name ol-2015-02376h_0003.jpg

entry solvent time (h) eeb (%)
1 toluene 8.0 91
2 2:1 hexane/toluene 8.0 88
3 MTBE 1.0 87
4 THF 1.0 81
a

Conditions: β-ketoester 13b (0.19 mmol), Pd2(dba)3 (2.75 mol %), (S)-L2 (6.00 mol %), toluene (5.8 mL).

b

Measured by analytical chiral SFC.

Subsequently, we explored the substrate scope of the enantioselective allylic alkylation of cyclopentanones. We found that our reaction manifold was tolerant of a variety of substitution at the α-position of the cyclopentanone (Scheme 2).16 Alkyl-substituted α-Cq cyclopentanones (S)-14c, (S)-14d, and (S)-14e were each produced over reaction times greater than 30 h with ee’s ranging from 86% to 88%, providing the more sterically congested cyclopentanone (S)-14e over a slightly longer reaction time.13 Along with ester-substituted cyclopentanone (S)-14b, nitrile (S)-14f and phthalamide (S)-14g were both produced quite rapidly at 20 °C in excellent yield with good ee (2.5 h, 97% yield, 87% ee and 3.0 h, 93% yield, 88% ee, respectively). We found that we could increase the ee of these two products significantly by lowering the temperature without any deleterious effect on the yield, providing cyclopentanones (S)-14f and (S)-14g in an improved 90% ee and 93% ee, respectively, at 0 °C over 23.0 h. This result represents a dramatic improvement in the formation of (S)-14g compared to our previously reported system, employing THF as the solvent with (S)-L1 as the ligand, which provided (S)-14g in only 67% yield with 48% ee.3d Comparatively, benzyl-substituted cyclopentanones proved to have a correlation between the electronics of the aryl substituent and the overall reaction time. Electron rich p-OMe-benzyl cyclopentanone (S)-14h was furnished in only 8.0 h, while the electron-neutral benzyl and p-Me-benzyl products ((S)-14i and (S)-14a) were each provided over a slightly extended reaction time (13.0 h). Contrastingly, the reaction producing electron poor p-CF3-benzyl-substitued (S)-14j failed to proceed to full conversion over 96.0 h, affording the product in a reduced 56% overall yield (83% yield based on recovered β-ketoester). Interestingly, despite the variable reaction times, the ee of the benzyl-substituted cyclopentanone products was largely consistent (88%–89% ee), with a slight boost for the electron-rich p-OMe-benzyl product ((S)-14h) to 92% ee.

Scheme 2. Substrate Scope of Cyclopentanone Substitution in Enantioselective Allylic Alkylation.

Scheme 2

Unless otherwise noted, all reported yields are isolated yields. Enantiomeric excess (ee) was determined by either analytical chiral SFC or HPLC.

Conditions: β-ketoester 13 (0.19 mmol), Pd2(dba)3 (2.75 mol %), (S)-L2 (6.00 mol %), toluene (5.8 mL).

Cyclopentanone product was volatile, resulting in a reduced isolated yield compared to other substrates.

Reaction performed at 0 °C.

Yield reported based on recovered β-ketoester starting material. Isolated yield was 56%.

Additionally, we found that indanones were competent substrates within our reaction manifold (Scheme 3).3d,5a,5d,7g Methyl-substituted indanone product (S)-16a was furnished over a greatly shortened 4.5 h compared to the methyl-substituted cyclopentanone product ((S)-14c, see Scheme 2). Additionally, bicycle (S)-16a was provided in 94% yield with 84% ee. Comparatively, the fluorinated analog (S)-16b was produced in an improved >99% yield and 87% ee, albeit over a longer reaction time (13.0 h).

Scheme 3. Enantioselective Allylic Alkylation of Indanone Substrates.

Scheme 3

Having investigated the tolerance of our reaction manifold to a variety of substitutions on the cyclopentanone ring, we next evaluated the potential to use 2-substituted allyl fragments in the enantioselective allylic alkylation of cyclopentanones (Scheme 4). Methyl- and ethyl-substituted cyclopentanone products (S)-6a and (S)-6b containing a 2-phenylallyl fragment were both produced in excellent yield and with 90% and 94% ee, respectively. Comparatively, cyclopentanones (S)-6c and (S)-6d, each containing a 2-chloroallyl fragment, were produced with similar ee’s in slightly reduced yield. Interestingly, each of the alkyl-substituted cyclopentanone products possessing a 2-substituted allyl fragment were produced over a shorter reaction time than the same substrates containing an unsubstituted allyl fragment (see Scheme 2).

Scheme 4. Enantioselective Allylic Alkylation of Cyclopentanone Substrates with 2-Substituted Allyl Fragments.

Scheme 4

All reported yields are isolated yields. Enantiomeric excess (ee) was determined by analytical chiral SFC.

Conditions: β-ketoester 5 (0.19 mmol), Pd2(dba)3 (2.75 mol %), (S)-L2 (6.00 mol %), toluene (5.8 mL).

Lastly, we examined the potential to apply our recently disclosed palladium(II) low catalyst loading protocol for enantioselective decarboxylative allylic alkylation to this new substrate class.17 We discovered that on a small scale, ester-substituted cyclopentanone (S)-14b was provided in an identical 91% ee and an improved 98% yield at 20 °C using only 0.15 mol % palladium catalyst (Scheme 5) compared to our palladium(0)-mediated reaction conditions, which employ 5.50 mol % palladium (vide supra). Increasing the scale of the reaction slightly (0.22 mmol) as well as the temperature (28 °C) and catalyst loading (0.30 mol % Pd) furnished (S)-14b over a reduced 18 h in 96% yield with 89% ee. Using these reaction conditions and increasing the scale 17 times (3.73 mmol) provided (S)-14b with identical 89% ee, although in a slightly diminished 82% yield.

Scheme 5. Low Catalyst Loading Palladium(II)-Mediated Enantioselective Allylic Alkylation.

Scheme 5

All reported yields are isolated yields. Enantiomeric excess (ee) was determined by analytical chiral SFC.

Pd(OAc)2 (0.15 mol %), (S)-L2 (1.50 mol %) used.

In conclusion, we have disclosed the first general method for the construction of α-Cq cyclopentanones by enantioselective palladium-catalyzed decarboxylative allylic alkylation. The reaction manifold proved optimal when electron-deficient (S)-(p-CF3)3-t-BuPHOX ((S)-L2) was employed, providing a variety of substituted cyclopentanone products in up to near-quantitative yield and with up to 94% ee. Additionally, the enantioselective allylic alkylation was found to be tolerant of allyl fragments substituted at the 2-position. Use of low-catalyst loading, palladium(II)-mediated reaction conditions was successfully accomplished, facilitating the synthesis of α-Cq cyclopentanones on increased scale in a cost-effective manner. Currently, our laboratory is pursuing further development of this technology through substrate scope extension and application in natural product synthesis.

Acknowledgments

We thank the NIH-NIGMS (R01GM080269 and postdoctoral fellowship F32GM073332 to A.M.H.), Amgen, the Gordon and Betty Moore Foundation, and Caltech for financial support. R.A.C. gratefully acknowledges the support of this work provided by a predoctoral fellowship from the National Cancer Institute of the National Institutes of Health under Award No. F31A17435. Additionally, we thank Eli Lilly (predoctoral fellowship to J.T.M.) and the Fannie and John Hertz Foundation (predoctoral fellowship to D.C.B.).

Supporting Information Available

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.orglett.5b02376.

  • Experimental details, characterization data, and NMR and IR spectra (PDF)

Author Contributions

R.A.C. and S.A.L. contributed equally.

The authors declare no competing financial interest.

Supplementary Material

ol5b02376_si_001.pdf (7.1MB, pdf)

References

  1. a Liu Y.; Han S. J.; Liu W. B.; Stoltz B. M. Acc. Chem. Res. 2015, 48, 740–751 10.1021/ar5004658. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Minko Y.; Pasco M.; Lercher L.; Botoshansky M.; Marek I. Nature 2012, 490, 522–526 10.1038/nature11569. [DOI] [PubMed] [Google Scholar]; c Das J. P.; Marek I. Chem. Commun. 2011, 47, 4593–4623 10.1039/c0cc05222a. [DOI] [PubMed] [Google Scholar]; d Weaver J. D.; Recio A.; Grenning A. J.; Tunge J. A. Chem. Rev. 2011, 111, 1846–1913 10.1021/cr1002744. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Douglas C. J.; Overman L. E. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 5363–5367 10.1073/pnas.0307113101. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Martin S. F. Tetrahedron 1980, 36, 419–460 10.1016/0040-4020(80)80024-X. [DOI] [Google Scholar]
  2. Behenna D. C.; Stoltz B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045 10.1021/ja044812x. [DOI] [PubMed] [Google Scholar]
  3. a Korch K. M.; Eidamshaus C.; Behenna D. C.; Nam S.; Horne D.; Stoltz B. M. Angew. Chem., Int. Ed. 2015, 54, 179–183 10.1002/anie.201408609. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Numajiri Y.; Pritchett B. P.; Chiyoda K.; Stoltz B. M. J. Am. Chem. Soc. 2015, 137, 1040–1043 10.1021/ja512124c. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Reeves C. M.; Behenna D. C.; Stoltz B. M. Org. Lett. 2014, 16, 2314–2317 10.1021/ol500355z. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Behenna D. C.; Mohr J. T.; Sherden N. H.; Marunescu S. C.; Harned A. M.; Tani K.; Seto M.; Ma S.; Novak Z.; Krout M. R.; McFadden R. M.; Roizen J. L.; Enquist J. A. Jr.; White D. E.; Levine S. R.; Petrova K. V.; Iwashita A.; Virgil S. C.; Stoltz B. M. Chem. - Eur. J. 2011, 17, 14199–14223 10.1002/chem.201003383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. a Craig R. A. II; Stoltz B. M. Tetrahedron Lett. 2015, 56, 4670–4673 10.1016/j.tetlet.2015.06.039. [DOI] [PMC free article] [PubMed] [Google Scholar]; b McDougal N. T.; Streuff J.; Mukherjee H.; Virgil S. C.; Stoltz B. M. Tetrahedron Lett. 2010, 51, 5550–5554 10.1016/j.tetlet.2010.08.039. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Krout M. R.; Mohr J. T.; Stoltz B. M. Org. Synth. 2009, 86, 181–205 10.1002/0471264229.os086.19. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Sprinz J.; Helmchen G. Tetrahedron Lett. 1993, 34, 1769–1772 10.1016/S0040-4039(00)60774-8. [DOI] [Google Scholar]; e Dawson G. J.; Frost C. G.; Williams J. M. J.; Coote S. J. Tetrahedron Lett. 1993, 34, 3149–3150 10.1016/S0040-4039(00)93403-8. [DOI] [Google Scholar]; f Von Matt P.; Pfaltz A. Angew. Chem., Int. Ed. Engl. 1993, 32, 566–568 10.1002/anie.199305661. [DOI] [Google Scholar]
  5. a Trost B. M.; Xu J.; Schmidt T. J. Am. Chem. Soc. 2009, 131, 18343–18357 10.1021/ja9053948. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Burger E.; Barron B.; Tunge J. Synlett 2006, 17, 2824–2826 10.1055/s-2006-950265. [DOI] [Google Scholar]; c Mohr J. T.; Behenna D. C.; Harned A. M.; Stoltz B. M. Angew. Chem., Int. Ed. 2005, 44, 6924–6927 10.1002/anie.200502018. [DOI] [PubMed] [Google Scholar]; d Trost B. M.; Xu J. J. Am. Chem. Soc. 2005, 127, 2846–2847 10.1021/ja043472c. [DOI] [PubMed] [Google Scholar]
  6. Reeves C. M.; Eidamshaus C.; Kim J.; Stoltz B. M. Angew. Chem., Int. Ed. 2013, 52, 6718–6721 10.1002/anie.201301815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. a Trost B. M. Tetrahedron 2015, 71, 5708–5733 10.1016/j.tet.2015.06.044. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Nahra F.; Macé Y.; Boreux A.; Billard F.; Riant O. Chem. - Eur. J. 2014, 20, 10970–10981 10.1002/chem.201404015. [DOI] [PubMed] [Google Scholar]; c Rambla M.; Duroure L.; Chabaud L.; Guillou C. Eur. J. Org. Chem. 2014, 2014, 7716–7720 10.1002/ejoc.201403161. [DOI] [Google Scholar]; d Nahra F.; Macé Y.; Lambin D.; Riant O. Angew. Chem., Int. Ed. 2013, 52, 3208–3212 10.1002/anie.201208612. [DOI] [PubMed] [Google Scholar]; e Huang J. Z.; Jie X. K.; Wei K.; Zhang H.; Wang M. C.; Yang Y. R. Synlett 2013, 24, 1303–1306 10.1055/s-0033-1338447. [DOI] [Google Scholar]; f Nahra F.; Macé Y.; Lambin D.; Riant O. Angew. Chem., Int. Ed. 2013, 52, 3208–3212 10.1002/anie.201208612. [DOI] [PubMed] [Google Scholar]; g Nakamura M.; Hajra A.; Endo K.; Nakamura E. Angew. Chem., Int. Ed. 2005, 44, 7248–7251 10.1002/anie.200502703. [DOI] [PubMed] [Google Scholar]; h Trost B. M.; Pissot-Soldermann C.; Chen I. Chem. - Eur. J. 2005, 11, 951–959 10.1002/chem.200400558. [DOI] [PubMed] [Google Scholar]; i Doyle A. G.; Jacobsen E. N. J. Am. Chem. Soc. 2005, 127, 62–63 10.1021/ja043601p. [DOI] [PubMed] [Google Scholar]; j Sawamura M.; Nagata H.; Sakamoto H.; Ito Y. J. Am. Chem. Soc. 1992, 114, 2586–2592 10.1021/ja00033a035. [DOI] [Google Scholar]
  8. Wellington K. D.; Cambie R. C.; Rutledge P. S.; Bergquist P. R. J. Nat. Prod. 2000, 63, 79–85 10.1021/np9903494. [DOI] [PubMed] [Google Scholar]
  9. Abbas H. K.; Mirocha C. J. Appl. Environ. Microbiol. 1988, 54, 1268–1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Asai R.; Mitsuhashi S.; Shigetomi K.; Miyamoto T.; Ubukata M. J. Antibiot. 2011, 64, 693–696 10.1038/ja.2011.73. [DOI] [PubMed] [Google Scholar]
  11. Takayama H.; Katakawa K.; Kitajima M.; Yamaguchi K.; Aimi N. Tetrahedron Lett. 2002, 43, 8307–8311 10.1016/S0040-4039(02)02026-9. [DOI] [Google Scholar]
  12. Oh H.; Swenson D. C.; Gloer J. B.; Wicklow D. T.; Dowd P. F. Tetrahedron Lett. 1998, 39, 7633–7636 10.1016/S0040-4039(98)01692-X. [DOI] [Google Scholar]
  13. Absolute configuration of cyclopentanone (S)-19 was determined by comparison of the optical rotation of the methyl ketone Wacker product to the known literature value; see:Thominiaux C.; Roussé S.; Desmaële D.; d’Angelo J.; Riche C. Tetrahedron: Asymmetry 1999, 10, 2015–2021 10.1016/S0957-4166(99)00180-9. [DOI] [Google Scholar]; The absolute configuration of all other products generated herein was assigned by analogy to the absolute configuration of (S)-19. For full details, see the Supporting Information.
  14. Additionally, silyl enol ether derivatives of cyclopentanones were found to be suitable enolate precursors for the formation of α-Cq cyclopentanones under similar reaction conditions with an external allyl electrophile. See the Supporting Information.
  15. McDougal N. T.; Virgil S. C.; Stoltz B. M. Synlett 2010, 11, 1712–1716 10.1055/s-0030-1258094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Additionally, α′,α′-disubstituted cyclopentanones were suitable substrates within the disclosed reaction manifold, albeit generally giving the α-Cq cyclopentanone products in reduced yields and with slightly diminished ee. β,β-disubstituted cyclopentanones were not suitable substrates under the optimized conditions. See the Supporting Information for full details.
  17. Marziale A. N.; Duquette D. C.; Craig R. A. II; Kim K. E.; Liniger M.; Numajiri Y.; Stoltz B. M. Adv. Synth. Catal. 2015, 357, 2238–2245 10.1002/adsc.201500253. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ol5b02376_si_001.pdf (7.1MB, pdf)

Articles from Organic Letters are provided here courtesy of American Chemical Society

RESOURCES